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Summary
A novel glycoprotein (gp) expressed by stromal cells of peripheral lymphoid tissue has been
characterized immunohistochemically, biochemically, and at the molecular level . This molecule,
gp38, was identified with a monoclonal antibody (mAb) (clone 8.1.1) previously shown to react
with a subpopulation of thymic epithelium. This mAb generated a reticular labeling pattern
in medullary and paracortical areas oflymph nodes and in splenic white pulp. At the ultrastructural
level, labeling by the 8.1.1 mAb was restricted to fibroblastic reticular stromal cells. Serial sections
oflymph node and spleen labeled with anti-CD3, anti-B220, and 8.1.1 mAbs clearly showed
that the 8.1.1' cells were associated with T cell-dependent areas . In severe combined immuno-
deficiency (SCID) or Nu/Nu mice, splenic white pulp also exhibited reticular labeling with the
8.1.1 mAb in the absence of detectable numbers of T cells, indicating that the appearance of
8.1.1-reactive stromal cells in discrete areas ofperipheral lymphoid tissue was T cell independent .
The cDNA encoding this stromal cell molecule was cloned by direct expression in COS cells
and found to encode a 172 amino acid sequence with the typical features of a type I integral
membrane protein . COS cells transfected with the gp38 clone direct the expression of an
approximately 38-kD protein that reacts with the 8 .1.1 mAb but not with isotype-matched controls.
Comparison of the predicted amino acid sequence of 8.1.1 mAb but not with isotype-matched
controls. Comparison of the predicted amino acid sequence of 8.1.1 with proteins in the National
Biomedical Research Foundation (NBRF) data base showed that gp38 is very closely related
to the early response protein OTS-8 obtained from a cDNA library of tumor promoting agent
(TPA)-induced murine osteoblastic cell line, MC3T3-E1 .
Peripheral lymphoid tissues are very compartmentalized
with respect to the distribution of different lymphocyte
populations (1, 2) . The basis for this compartmentalization
oflymphocyte populations within peripheral lymphoid tissue
is poorly understood. Observations that different populations
of nonlymphoid cells also exhibit differential localization
within lymphoid tissues has led to the notion that the ob-
served compartmentalization of lymphocyte subpopulations
may be dependent on lymphocyte interactions with different
populations of nonlymphoid cells located within distinct ana-
tomic compartments of lymphoid tissue (3, 4) . At least four
major types ofnonlymphoid stromal cells have been identified
within peripheral lymphoid tissue on the basis of distinctive
morphologic and phenotypic criteria : follicular dendritic re-
ticular cells (5, 6), cells of the mononuclear phagocyte lin-
eage (7, 8), interdigitating or dendritic cells (9-11), and ex-
trafollicular reticular cells (11-13) .
In this report, we describe the cloning and characteriza-
tion of a cell surface glycoprotein, gp38, that is preferentially
expressed by stromal cells in T cell-dependent areas of pe-
ripheral lymphoid tissue and has been previously shown to




Male and female BALB/c mice were pur-
chased from Bantin and Kingman, Inc. (Fremont, CA) and main-
tained in the Department of Biological Structure vivarium. For
timed pregnancies, the appearance of a vaginal plug was consid-
ered to be day 0 of gestation . Adult tissue was obtained from 4-8-
wk-old mice . SCID mice (15) were generously provided by Dr .
F . Smith (Fred Hutchinson Cancer Research Center, Seattle, WA) .
All procedures involving animals followed institutional guidelines
established by the Department of Comparative Medicine at the
University of Washington .
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Thefollowing mAbs were used in the
form of culture medium from exhaustively grown hybridomas, or
purified and conjugated with biotin or horseradish peroxidase as
previously described (16) : anti-rat « chain, clone RG7/9.1 (17) ;
anti-IA"', clone34 .5 .3 (18) ; anti-B220, clone 14.8 (19) ; anti-CD3,
clone 500A2 (20) ; and 8 .1.1, a hamster mAb reacting with sub-
capsular andmedullary thymic epithelium, as well as epithelial and
mesenchymal cells of multiple tissues (14) . Biotinylated and
peroxidase-labeled goat anti-hamster IgG antibodies were purchased
from Caltag Laboratories (South San Francisco, CA) . A hamster
mAb, clone F531 (kindly provided by Dr. J . Allison, University
of California, Berkeley) was used as a negative control in these
studies . Goat anti-hamster antibodies were purchased from Caltag
Laboratories and iodinated using iodogen (Pierce Chemical Co .,
Rockford, IL) . Na'ZSI was purchased from New England Nuclear
(Boston, MA) . Except where noted, other reagents were obtained
from Sigma Chemical Co . (St . Louis, MO).
The cell lines utilized in this study included the thymic lym-
phoma, ELA (21), the keratinocyte cell line, PAM-212 (22), the
medullary thymic epithelial cell line, TE-71 (23), and a panel of
thymic stromal cells derived from transgenic mice bearing theSV40
large T antigen driven by the lck promoter (24) .
Immunohistochemistry and Biochemistry.
￿
The techniques used for
light and electron microscopic immunohistochemistry have been
described in detail (14) . Forimmunoblot analysis of8.1 .1 reactivity,
neonatal thymuses or pooled axillary and mesenteric lymph nodes
from 6-10-wk-old mice were minced with a razor blade to generate
tissue fragments . Afterwashing repeatedly with HBSS using unit
gravity sedimentation to remove lymphocytes, stroma fragments
were processed forimmunoblot analysis as described previously (14) .
Cloning and Nucleic Acid Analyses.
￿
Protocols for the prepara-
tion of a TE 71cDNA library and the expression cloning system
utilized have been previously described (25, 26) .
Probing ofmRNA andgenomicDNAprepared from cell lines
and tissue utilized standard methods. Asingle-stranded probe com-
plimentary to gp38 transcript wasmade from single-strandedCDMS
vector containing gp38 cDNA . By using a primer 5' of the gp38
insert and limiting amountsof dCTP, only the CDM8 vector was
labeled (27) . For Southern and Northern blot hybridization of
tissues, the gp38 insert was excised from the CDMS vector by an
Xbal digest and purified from alow melting temperature agarose
gel using Gene Clean (Bio 101, Inc., La Jolla, CA) . Theprobewas
then labeled viarandom primer extension . To confirm equal loading
of RNA, a probe was made from rat glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) cDNA (28) via random primer exten-
sion (Boehringer Mannheim Corp ., Indianapolis, IN) .
Results and Discussion
Immunohistology ofPeripheral Lymphoid Tissue.
￿
In aprevious
study we have identified a 36-40 kD glycoprotein expressed
by medullary thymic epithelial cells with themAb 8.1.1 (14) .
Herewe have shown this molecule is also expressed by stromal
cells in Tcell-dependent areas of peripheral lymphoid tissues.
The staining pattern of the 8.1.1 mAb in lymph nodes was
reticular within discrete areas . Follicular areas of the lymph
node contained only a few scattered 8.1.1+ cells, whereas the
paracortical areas and medullary cords were well decorated
with peroxidase reaction product (Fig. 1 a) .
In the spleen, the antigen detected by the 8.1.1 mAb was
preferentially associated with the splenic white pulp, with
the most intense labeling associated with the periarteriolar
lymphatic sheath (PALS) and adjacent reticular cells (Fig. 1
b) . Although this mAb may react with cells in the splenic
redpulp, the intensityoflabeling in redpulp resembled back-
ground staining observed with an irrelevant hamster primary
antibody or the anti-hamster Ig secondary antibody alone
(Fig . 1 c) . Mesothelium covering the capsule of the spleen
was also labeled (data not shown) .
The association of 8.1.1' stromal cells with T cell-depen-
dent areas of the lymph node was clearly revealed whenT
and B cell-dependent areas of spleen and lymph node were
identified in frozen sections serial to sections labeled with
8 .1 .1 mAbs, using anti-CD3 and anti-B220 mAbs, respec-
tively (Fig. 2) . As shown in Fig . 2 a, and in agreement with
Figure 1.
￿
Reactivity of the 8.1 .1 mAb with peripheral lymphoid tissue . (a) Lymph node cortex and paracortex . (FO) follicle ; (PC) paracortex. (b)
White pulp of spleen . (Arrow) Obliquely sectioned central artery. (Arrowheads) Perimeter of 8.1 .1 labeling in white pulp. (c) Background labeling of
spleen with irrelevant hamster Ig followed by goat anti-hamster IgG antibodies. Note the background reaction product in red pulp area at bottom
of the field . x60-70 .
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Association of 8 .1.1' stromal cells with T cell-dependent areas of lymph node and spleen . In a-c, adjacent serial sections of spleen were
labeled with anti-CD3, 8 .1 .1 mAb, and anti-B220, respectively. The central artery (") serves as a point of reference in the three sections . In d-f, adjacent
serial sections of lymph node were labeled with anti-CD3, 8 .1 .1 mAb, and anti-B220, respectively. (FO) Follicle ; (PC) paracortex . x80 .
previous descriptions of splenic white pulp (29), T cells were
concentrated in a perivascular location adjacent to the cen-
tral artery ofthe white pulp. The reactivity ofthe 8.1 .1 rnAb
with the adjacent serial section (Fig. 2 b) revealed a reticular
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organization of stromal cells which corresponded well to the
T cell-dependent area of the white pulp. Areas of the white
pulp largely devoid of 8.1.1 stromal cells corresponded to B
cell-dependent areas, as indicated by reactivity of adjacent
Figure 3 .
￿
Ultrastructure of 8 .1.1' cell in
lymph node paracortex. Stromal cell surface in
contact with lymphoid cells bears reaction pro-
duct (arrows) . (Arrowheads) Stromal cell mem-
brane investing a reticular fiber bundle (') is
not labeled . (SC) Stromal cell . x4,500.Figure 4 .
￿
gp38 cDNA encodes
a protein detected by 8 .1.1
mAb. Immunoblot comparison of
TE-71 withCOS cells transfected
with gp38 cDNA (clone 14) .
Samples were probed with 8 .1.1
mAb and an irrelevant mAb
(500A2) . Molecular weights of
standard proteins are shown in
kD .
serial sections with an anti-B cell reagent antibody (Fig . 2
c) . Similar studies oflymph node tissue (Fig. 2, d-f) demon-
strated a relative paucity of 8.1.1+ stromal cells in the B
cell-dependent cortical follicles . Reactivity of lymph node
or splenic white pulp with peroxidase labeled goat anti-ham-
ster or goat anti-rat IgG was minimal and resembled the en-
dogenous peroxidase controls (data not shown) .
At the ultrastructural level, labeling by the 8.1.1 antibody
was restricted to reticular stromal cells in both spleen and
lymph node (Fig. 3) . No reaction product was detected in
association with lymphoid cells, macrophages, or dendritic
cells. Occasional perivascular stromal cells exhibited polarized
reactivity with the 8.1.1 antibody and were devoid of reac-
tion product at areas in contact with the basal lamina (data
not shown) . The stromal cell nature of the labeled cells was
reflected by their investment around bundles ofreticular fibers .
As with the perivascular reticular cells, the segments of the
stromal cell membranes investing the extracellular matrix of
the reticular fibers were not labeled with the 8.1.1 antibody.
In terms ofother mAbs reacting with extrafollicular stromal
cells of peripheral lymphoid tissue, the localization pattern
observed with 8.1.1 is more restricted than reported for ER-
TR7 (12) or for ED11-15 (13) mAbs. The 8.1.1 labeling pat-
terns in peripheral lymphoid tissue, thymus (14), and bone
marrow (data not shown) closely resemble those described
in the rat by Van den Berg et al . (13) for the ED10 mAb.
The presence of an 8.1.1+ stromal cell population in peri-
arteriolar areas of splenic white pulp from SCID or Nu/Nu
mice (data not shown) indicate that the development of this
stroma cell population occurs independently ofT cells. Our
results also indicate that expression of gp38 by this popula-
tion of stromal cells is not dependent on interactions with
T cells and/or their products . Consistent with this latter ob-
servation, we have observed little if any effect of cytokines
(IIA, TNF-ot, IFN-y, or 114) on the reactivity of thymic






Cloning of the gp38
revealed a 172-amino acid-long type I membrane protein with
a putative 20-amino acid-long amino terminal secretory signal
sequence, followed by an extracellular domain rich in both
Ser and Thr residues and containing one potential Winked
glycosylation site, a hydrophobic transmembrane domain, and
a short cytoplasmic domain (EMBL accession no. M96645) .
Although the predicted size of the protein encoded by the
gp38 cDNA is 16 kD, transfection of this cDNA into COS
cells directs the expression of a 40 kD protein which is rec-
ognized by the 8.1.1 mAb (Fig. 4) . The large discrepancy
between theM r and the predicted molecular mass of 16 kD
might be due to the presence of N-linked and/or O-linked
carbohydrates on the mature protein . The broad banding pat-
tern exhibited by this molecule in immunoprecipitation studies
with TE-71 cells and COS cell transfectants and immuno-
blot analysis of lymph node stroma (data not shown) sug-
gests that gp38 is variably glycosylated. The presence of mul-
tiple Ser and Thr residues in the extracellular domain ofgp38
and our previous observations that gp38 binds wheat germ
lectin and that N-glyconase treatment failed to alter theMr
of gp38 (14) would be consistent with the notion that gp38
bears 0-linked carbohydrates . The apparent discrepancy in
size may also reflect other posttranslational modifications, such
as myristylation, sulfation, or phosphorylation (30-32) . Similar
discrepancies in size between theMr of deglycosylated pro-
teins and their predictedMr have been reported for N-CAM
and MRC OX-2 (33, 34) .
The gp38 probe detected a single species ofRNA with
a molecular size of 2 kb inRNA samples isolated from mu-
rine fibroblast 3T3 cells and several thymic stromal cell lines
(186CC, Z172,Z199, Z210, Z210R.1.7, and TE-71), but not
with poly(A) RNA isolated from a T cell lymphoma or ker-
atinocyte cell'line. A similar sized RNA species from thymus,
spleen, lymph node, and skin also hybridized with the gp38
probe (data not shown). Blot hybridization analysis ofgenomic
DNA isolated from the murine cell lines TE-71 and PAM
212 showed identical patterns after digestion with BamHI,
EcoRI, HindIII, KpnI, PvuII, PstI, ScaI, or XbaI restriction
enzymes and binding to a radiolabeled gp38-specific probe
(data not shown) .
Although RNA blot analysis indicates that the size of the
gp38 cDNA described here is significantly smaller than the
mRNA found in cell lines known to express gp38 (data not
shown), the finding that this cDNA directs the expression
of an 8.1.1-reactive molecule with the same molecular weight
as that obtained from cell lines that express gp38 indicates
that this cDNA contains all or almost all of the gp38 coding
sequence. Further work is needed to isolate a full-length copy
of the gp38 transcript and verify that the cDNA described
here does contain the complete gp38 coding sequence. DNA
blot analysis with genomicDNA isolated from 8.1.1+ and
8.1.1 - cell lines suggest that gross genomic rearrangements
are not involved in controlling gp38 expression (data not
shown) .
Comparison ofthe predicted amino acid sequence of gp38
with those in the National Biomedical Research Foundation(NBRF) data base using the FASTP algorithm contained in
the University of Wisconsin Genetic Computing Group
(GCG) software (35) package showed that gp38 was closely
related to the TPA-inducible gene, OTS-8 isolated from
MC3T3-E1 cells, a murine osteoblastic cell line (36) . Five
differences in the nucleotide sequences were observed in the
5' end of the gp38 coding sequence. These occur at nucleo-
tide positions 160, 164, 167, 189, and 191 (all nucleotide num-
bering here is based on the gp38 cDNA) . In each case, the
gp38 cDNA contains adenine nucleotides in these positions,
whereas the OTS-8 cDNA contains guanine nucleotides in
these positions. These differences resulted in changes in the
predicted amino acid sequence from K, N, N, E, and N in
gp38 to E, D, D, G, and D in OTS-8 for residues 9, 10, 11,
18, and 19, respectively (all amino acid numbering is based
on the mature gp38 protein) . One additional difference was
found at the 3' end of the gp38 coding sequence which con-
tained a thymine nucleotide at position 585 absent in the






cDNA) . This results in a change of frame that alters amino
acids 151-153 and also moves the stop codon position, such
that the cytoplasmic domain of the OTS-8 protein was 33
residues longer than that of gp38 (amino acid numbering
is based on the mature gp38 protein) .
Although it was predicted that the OTS-8 gene product
would be a secreted protein (36), flow cytometric analyses
of 8.1.1 reactivity with stromal cell lines (14, and data not
shown) and the fact that the gp38cDNA directs the cell sur-
face expression of gp38 by transfected COS cells (data not
shown) clearly demonstrate that gp38 is expressed on the cell
surface. It remains to be determined how these two proteins
are functionally related and if they represent members of a
new gene family.
At this time the function of gp38 is not known . We are
presently constructing gp38-Ig recombinant fusion protein
to identify possible ligands for gp38 and to examine the pos-
sible involvement of this molecule in T lymphocyte differen-
tiation and/or functional organization of lymphoid tissue .
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